Death Scare For Pfizer's Pipeline Star Tofacitinib May Be Just A Storm In a Teacup
This article was originally published in The Pink Sheet Daily
Executive Summary
Mortality rate for Pfizer's oral RA drug tofacitinib is similar to what's been seen with established TNF blockers, which have labels warning of potential for death by infection and cancer.